Sensei Biotherapeutics, Inc.
Developing tumor-activated biologics to stimulate a targeted immune response against cancer.
SNSE | NDAQ
Overview
Corporate Details
- ISIN(s):
- US81728A1088
- LEI:
- Country:
- United States of America
- Address:
- 1405 RESEARCH BLVD, SUITE 125, 20850 ROCKVILLE
- Website:
- https://www.senseibio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sensei Biotherapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and developing next-generation therapeutics for cancer patients. The company's approach is centered on understanding the tumor microenvironment to create highly selective treatments. Through its proprietary TMAb™ (Tumor Microenvironment Activated biologics) platform, Sensei develops conditionally active antibodies designed to activate specifically within the tumor. This targeted mechanism aims to stimulate the patient's immune system to recognize and attack cancer cells, addressing challenging immuno-oncology targets while potentially minimizing off-tumor side effects.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Sensei Biotherapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sensei Biotherapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sensei Biotherapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
